Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial

Autor: Croop, Robert *, Lipton, Richard B, Kudrow, David, Stock, David A, Kamen, Lisa, Conway, Charles M, Stock, Elyse G, Coric, Vladimir, Goadsby, Peter J
Zdroj: In The Lancet 2-8 January 2021 397(10268):51-60
Databáze: ScienceDirect